How to Cite
Abstract
.
References
Davidson MH, Rosenson RS. Novel targets that affect high-density lipoprotein metabolism: the next frontier. Am J Cardiol 2009;104 (10 Suppl):52E-7E. https://doi.org/10.1016/j.amjcard.2009.09.020
Navab M, Anantharamaiah GM, Reddy ST et al. HDL as a biomarker, potential therapeutic target, and therapy. Diabetes 2009; 58:2711-7. https://doi.org/10.2337/db09-0538
Altschul R, Hoffer A, Stephen JD. Influence of nicotinic acid on serum cholesterol in man. Arch Biochem 1955; 54:558-559. https://doi.org/10.1016/0003-9861(55)90070-9
Maiese K, Chong ZZ, Hou J et al. The vitamin nicotinamide: translating nutrition into clinical care. Molecules. 2009 Sep 9; 14(9):3446-85. https://doi.org/10.3390/molecules14093446
Vosper H. Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia. Br J Pharmacol 2009; 158:429-41. https://doi.org/10.1111/j.1476-5381.2009.00349.x
Murphy AJ, Woollard KJ. High density lipoprotein - a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol 2009 Nov 23. [Epub ahead of print].
Sharma RK, Singh VN, Reddy HK. Thinking beyond lowdensity lipoprotein cholesterol: strategies to further reduce cardiovascular risk. Vasc Health Risk Manag. 2009; 5:793-9. https://doi.org/10.2147/VHRM.S5684
Carlson LA, Hanggren A. Initial distribution in mice of 3H-labelled nicotinic acid studied by autoradiography. Life Sci 1964; 3:867-871. https://doi.org/10.1016/0024-3205(64)90149-3
Butcher RW, Baird CE, Sutherland EW. Effects of lipolytic and antilipolytic substances on adenosine 3',5'- monophosphate levels in isolated fat cells. J Biol Chem 1968; 243:1705-1712. https://doi.org/10.1016/S0021-9258(18)93503-9
Aktories K, Jakobs KH, Schultz G. Nicotinic acid inhibits adipocyte adenylate cyclase in a hormone-like manner. FEBS Lett 1980; 115:11-14. https://doi.org/10.1016/0014-5793(80)80715-0
Aktories K, Schultz G, Jakobs KH. Islet-activating protein prevents nicotinic acid-induced GTPase stimulation and GTP but not GTP gamma S-induced adenylate cyclase inhibition in rat adipocytes. FEBS Lett 1983; 156:88-92. https://doi.org/10.1016/0014-5793(83)80254-3
Lorenzen A, Stannek C, Lang H et al. Characterization of a G protein coupled receptor for nicotinic acid. Mol Pharmacol 2001; 59:349-357. https://doi.org/10.1124/mol.59.2.349
Lorenzen A, Stannek C, Burmeister A et al. G proteincoupled receptor for nicotinic acid in mouse macrophages. Biochem Pharmacol 2002; 64:645-648. https://doi.org/10.1016/S0006-2952(02)01220-0
Schaub A, Fu˝tterer A, Pfeffer K. PUMA-G, an IFN-ginducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur J Immunol 2001; 31:3714-3725. https://doi.org/10.1002/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1
Soudijn W, van Wijngaarden I, Ijzerman AP. Nicotinic acid receptor subtypes and their ligands. Med Res Rev 2007; 27:417-33. https://doi.org/10.1002/med.20102
OMIM [base de datos en Internet]. Baltimore: Johns Hopkins University; 1966- [citado 4 Feb 2010]. Disponible en: http://www.ncbi.nlm.nih.gov/omim/
Wise A, Foord SM, Fraser NJ et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003; 278:9869-9874. https://doi.org/10.1074/jbc.M210695200
Taggart AKP,Kero J, Gan X et al. (D)-b-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005; 280:26649-26652. https://doi.org/10.1074/jbc.C500213200
HUGO [base de datos en Internet]. Bethesda, Maryland: National Library of Medicine, Celera Genomics and the Sanger Center; 1989- [citado 4 Feb 2010]. Disponible en: http://www.hugo-international.org/index.html
Shen HC. Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO200 8051403. Expert Opin Ther Pat 2009; 19:1149-55. https://doi.org/10.1517/13543770902798061